CN Patent

CN110403939A — 用于治疗淋病奈瑟球菌感染的三环含氮化合物

Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2019-11-05 · 7y expired

What this patent protects

本发明涉及一种治疗淋病奈瑟球菌感染的方法，其包括向需要的受试者给药本文所述的新的三环含氮化合物及其相应的药物组合物。

USPTO Abstract

本发明涉及一种治疗淋病奈瑟球菌感染的方法，其包括向需要的受试者给药本文所述的新的三环含氮化合物及其相应的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number: CN110403939A
Jurisdiction: CN
Classification: —
Expires: 2019-11-05
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline Intellectual Property Development Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.